Trials / Conditions / Lipid Metabolism, Inborn Errors

Lipid Metabolism, Inborn Errors

14 registered clinical trials studyying Lipid Metabolism, Inborn Errors.

Status	Trial	Sponsor	Phase
Completed	Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies NCT05425745	NewAmsterdam Pharma	Phase 3
Unknown	Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid Diseases NCT02707211	Universitaire Ziekenhuizen KU Leuven	EARLY_Phase 1
Unknown	Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy NCT02635269	Rigshospitalet, Denmark	N/A
Terminated	Mendelian Reverse Cholesterol Transport Study NCT01782027	University of Pennsylvania	N/A
Completed	An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patie NCT00694109	Kastle Therapeutics, LLC	Phase 3
Completed	Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemi NCT00607373	Kastle Therapeutics, LLC	Phase 3
Completed	Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia NCT00477594	Kastle Therapeutics, LLC	Phase 2
Completed	Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration NCT00362180	Kastle Therapeutics, LLC	Phase 2
Terminated	Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency NCT00260299	Oregon Health and Science University	—
Completed	An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062) NCT00092898	Organon and Co	Phase 3
Terminated	Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPL NCT00092833	Organon and Co	Phase 3
Completed	Sitosterolemia Extension Study (0653-003)(COMPLETED) NCT00092807	Organon and Co	Phase 3
Completed	Sitosterolemia Extension Study (0653-004)(COMPLETED) NCT00092820	Organon and Co	Phase 3
Completed	Genetic Study of Sitosterolemia NCT00004481	National Center for Research Resources (NCRR)	—